Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Delivery of Diabetes Management During Breast Cancer Care

NCT05565534 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT05565534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05565534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Delivery of Diabetes Management During Breast Cancer Care
Lead sponsor
Weill Medical College of Cornell University
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2023
Completion date
October 6, 2025
Enrollment
74 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, prediabetes, type 2 diabetes